News / Events

EVERSANA is a proud Gold Sponsor of The Patient Congress

ENSURE THE PATIENT IS AT THE CENTER OF YOUR STRATEGY

EVERSANA was a proud sponsor of The Patient Congress, held this year in Philadelphia, PA. The two-day conference featured three tracks – Patient Adherence and Engagement, Patient Advocacy, and Rare Disease Market Access and Orphan Drug Commercialization – all focused on incorporating the patient voice across the entire product lifecycle. Diann Johnson, Executive Director of Business Development at EVERSANA and Bill O’Bryon, Managing Director of Digital at The Patient Experience Project, an EVERSANA Agency, shared insight into developing a launch plan for a rare disease from 3 perspectives: patients, payers, and patient services and distribution.

Hear Successes of a Rare Disease Product Launch Strategy to Ensure Market Success

Monday, March 11 at 4:30pm – Rare Disease Track

Bill O'Bryon

The differences in launching a rare disease are many: small patient populations, complex administration and side effects, the role of the caregiver, the importance of patient advocacy, and educating stakeholders (HCPs, caregivers, patients). Additionally, as this market matures, there are a number of evolving new issues that impact the market dynamics as well: an increased number of rare disease therapies coming to market, competing products, patient concerns over high cost of therapies, misconceptions about emerging therapies (gene therapy, CAR-T), government policy intervention, and who should shoulder the burden of the cost. All of these ingredients need to be considered and solved during launch planning.

In this landscape, value is more important now than ever before. Creating value requires stronger stakeholder relationships and advancing beyond the traditional outsourcing.

 Here are 3 key takeaways from this presentation:

Earn the value of the strongest patient relationships:

When it comes to reaching proactive and highly engaged patients, caregivers and providers, success depends on a creative, hands-on approach. In rare disease, patient populations are small so every patient is extremely important, which makes relationship building and true collaboration a requirement to building trust and loyalty. Successful engagement requires early, high-value content accessible through digital and social media to meet patients and caregiver where they are.

Demonstrate results to build the strongest payer relationships:

Payers are playing a bigger role, so it’s important to understand the payer landscape including competitive drugs and the importance of RWE data. Just like patients, caregivers and HCP, payers need education into these therapies so be sure to build that into your strategy to increase payer acceptance. Infuse value-based thinking into every step of the product lifecycle to best communicate the value story to payers. Then leverage the patient voice with payers to help humanize the experience and give texture to your value stories.

Fuel the strongest patient services and distribution relationships

Ensure a seamless experience for all constituents. Utilize the insights from patient assessments and experiences to design patient services programs that include education and resources as part of ongoing patient services support. Monitor these services as patients go through their lifecycle to ensure the programs continue to meet patient needs and make sure your channel and specialty distribution services are seamless, the ability to handle modern therapies such as CAR-T, gene therapies, and cold chain.

 

EVERSANA Sponsors the AMCP Annual Meeting

EVERSANA proudly sponsors The Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting. The annual meeting will be held March 25-28 at The San Diego Convention Center in San Diego, California. AMCP is dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health […]

EVERSANA Proudly Sponsors World Orphan Drug Congress

The Congress, held April 10-12 in Oxon Hill, MD, is the largest global annual gathering of orphan drug stakeholders focused on the evolving rare disease landscape. This year’s program has expanded to focus on cell and gene therapies for rare diseases as well as rare oncology, pricing and reimbursement, clinical development and regulatory, and advanced […]

Universal Medica Group and EVERSANA announce global medical information and pharmacovigiliance service partnership

PARIS – Universal Medica Group and EVERSANA today are pleased to announce that they have entered into a definitive partnership, increasing their global footprint and enhancing their expertise in the life sciences and healthcare industry. Universal Medica Group, an expert in healthcare and pharmaceutical services, will partner with EVERSANA, the leading independent provider of full […]

EVERSANA unveils new global market access research solutions from Health Strategies Insights

Chicago, IL,  – EVERSANA™, the leading independent provider of global services to the life science industry, introduced a new suite of global market access solutions from Health Strategies Insights to help biopharmaceutical manufacturers understand the latest global trends in access, payment, distribution and administration. The new offering, Global Market Access Insights, includes proven frameworks and […]

Promidian, an EVERSANA™ Company, named a top-performing firm by Consulting Magazine

Promidian, an EVERSANA™ Company, has been named a top-performing consulting firm by Consulting magazine. The publication has recognized Promidian as one of the 2019 “Seven Small Jewels” in its February/March issue. Described by Consulting as the hidden gems of the profession, the Seven Small Jewels represent smaller firms that are breaking new ground in terms […]

EVERSANA Sponsors Pharma Pricing & Market Access Congress

EVERSANA will be a key sponsor this year’s Pharma Pricing & Market Access Congress (PPMA), taking place on March 18 in Amsterdam, The Netherlands. From industry-leading global pricing solutions, market access and RWE, EVERSANA will showcase to the global marketplace how our integrated services came together into a single platform to create value across the […]

EVERSANA Sponsors ModelN Rainmaker Event

EVERSANA is a gold sponsor at this year’s Model N Rainmaker conference on March 18-20, 2019, taking place in Miami Beach. Robert Blank and Mike Kurland will be presenting a session on March 20, titled: Challenges and Best Practices in Managing Value Based Contracts. During this session they will discuss:   The obstacles associated with […]

EVERSANA sponsors CBI’s Patient Assistance & Access Programs Conference

EVERSANA is a proud sponsor of the 20th Patient Assistance & Access Programs conference organized by CBI.  Tom Doyle, our EVP of Commercial Solutions led a session on the impact of patient support programs. Measuring the Impact of Patient Support Programs Wednesday March 6th, 9:45am – General Session At a time of so much change, […]

EVERSANA™ appoints experienced life science industry leaders to executive management team

CHICAGO – EVERSANA™, the leading independent provider of global services to the life science industry, today announced three appointments to the executive leadership team. Greg Skalicky, Chief Revenue Officer, Tim Guttman, Chief Financial Officer, and Mark MacNaughton, Chief Information Officer, bring a combined 80 years of life science expertise to EVERSANA, bolstering its position as […]